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Abstract
The model white rot fungus Phanerochaete chrysosporium, which is known for its versatile pollutant-biodegradation ability,
possesses an extraordinarily large repertoire of P450 monooxygenases in its genome. However, the majority of these P450s
have hitherto unknown function. Our initial studies using a genome-wide gene induction strategy revealed multiple P450s
responsive to individual classes of xenobiotics. Here we report functional characterization of a cytochrome P450
monooxygenase, CYP5136A3 that showed common responsiveness and catalytic versatility towards endocrine-disrupting
alkylphenols (APs) and mutagenic/carcinogenic polycyclic aromatic hydrocarbons (PAHs). Using recombinant CYP5136A3,
we demonstrated its oxidation activity towards APs with varying alkyl side-chain length (C3-C9), in addition to PAHs (3–4
ring size). AP oxidation involves hydroxylation at the terminal carbon of the alkyl side-chain (v-oxidation). Structure-activity
analysis based on a 3D model indicated a potential role of Trp
129 and Leu
324 in the oxidation mechanism of CYP5136A3.
Replacing Trp
129 with Leu (W129L) and Phe (W129F) significantly diminished oxidation of both PAHs and APs. The W129L
mutation caused greater reduction in phenanthrene oxidation (80%) as compared to W129F which caused greater
reduction in pyrene oxidation (88%). Almost complete loss of oxidation of C3-C8 APs (83–90%) was observed for the W129L
mutation as compared to W129F (28–41%). However, the two mutations showed a comparable loss (60–67%) in C9-AP
oxidation. Replacement of Leu
324 with Gly (L324G) caused 42% and 54% decrease in oxidation activity towards
phenanthrene and pyrene, respectively. This mutation also caused loss of activity towards C3-C8 APs (20–58%), and
complete loss of activity toward nonylphenol (C9-AP). Collectively, the results suggest that Trp
129 and Leu
324 are critical in
substrate recognition and/or regio-selective oxidation of PAHs and APs. To our knowledge, this is the first report on an AP-
oxidizing P450 from fungi and on structure-activity relationship of a eukaryotic P450 for fused-ring PAHs (phenanthrene and
pyrene) and AP substrates.
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Introduction
Polycyclic aromatic hydrocarbons (PAHs) and alkylphenols
(APs) are two important groups of environmentally persistent and
highly toxic chemicals that have received much attention for their
slow biodegradation in the environment. Because of their
persistence, these chemicals have the potential to bioaccumulate
in the food-chain, causing adverse health effects in humans. PAHs
are mutagenic and/or carcinogenic, and APs are endocrine-
disrupting chemicals (EDCs) which can cause reproductive and
other adverse health effects. Among the few microorganisms
capable of oxidizing these persistent chemicals, fungi possess an
extraordinary ability to completely degrade and/or mineralize (to
CO2) these pollutants. However, little is known about the specific
enzymes capable of oxidizing these chemicals as part of the
biodegradation pathways in these microorganisms. Fungi have
been shown to possess the capability to oxidize PAHs via P450-
mediated mechanisms [1–3]. On the other hand, oxidation studies
on the model AP nonylphenol (NP) in fungi [4–9] have implicated
involvement of either extracellular oxidases [6–8] or hitherto
unidentified intracellular enzymes [8,9]. However, specific P450
genes/enzymes capable of oxidizing NP, or other APs, have not
yet been identified from this important group of pollutant-
oxidizing environmental organisms.
Phanerochaete chrysosporium (henceforth abbreviated as Pc), which
belongs to the white rot group of the wood decaying fungi, is the most
intensively studied white-rot fungus for its extraordinary ability to
oxidize and/or mineralize a broad range of environmental toxicants,
including PAHs and alkyl-substituted aromatics [10–12]. The whole
genome sequencing of P. chrysosporium [13] had uncovered large P450
diversity, namely about 149 P450 genes [14]. Recently, using a
genome-to-function strategy based on genome-wide expression
profiling combined with catalytic screening of the expressed proteins,
our laboratory first identified subsets of P450 genes in this fungus that
are inducible by the two groups of environmentally persistent
organopollutants of interest viz. APs [12] and PAHs [15]. One of
the inducible fungal P450s, CYP5136A3, showed common respon-
siveness to both APs and PAHs, implying its catalytic versatility.
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28286In light of these findings, the current study focuses on
CYP5136A3 to assess its catalytic versatility and structure-activity
relationship in terms of critical catalytic amino acid residues for
biodegradation of PAHs and APs. The resulting information could
improve strategies using P450-based biocatalysts for biotechno-
logical and bioremediation applications. Additionally, considering
the overall low sequence homology (12–23%) of this fungal P450
to its orthologs in humans and animals [16–20], it provides a
unique experimental model to expand our knowledgebase on
critical catalytic amino acid residues for oxidation of these
xenobiotics by the eukaryotic P450s, a topic of significant current
interest [21–23]. Indirectly, such basic information from a lower
eukaryotic P450 may also provide insights into our understanding
of the role of genetic polymorphisms at the active site in
modulating functional diversity in the xenobiotic- and drug-
metabolizing human or animal P450 enzymes.
Given the difficulties in heterologous expression of P450 genes
of this fungus [24,25], we have recently developed a yeast co-
expression system, wherein P. chrysosporium P450s (Pc-P450s) are
heterologously expressed in the active form along with the
homologous cytochrome P450 reductase (Pc-CPR) in Pichia
pastoris [15,26]. Whole cell-based P450 assays have an advantage
over in vitro enzyme reconstitution assays where uncoupling is the
major factor that interferes in estimation of the turnover of the
substrates. Hence, in this study, the whole cell biocatalyst strategy
was employed using the recombinant yeast to characterize the
catalytic properties of CYP5136A3 and its mutants
(W129{A,L,F} and L324G) towards APs and PAHs. Phenan-
threne and pyrene were used as the model compounds to
understand the PAH catalysis, whereas APs with varying alkyl-
chain length (C3-C9) were tested individually as model
alkylphenols, in addition to the technical grade nonylphenol
(tNP) that is comprised of more than 100 NP isomers containing a
quaternary a-carbon [27].
We observed broad substrate specificity of CYP5136A3 towards
linear APs (C3-C9) and the tNP mixture. The results provide
experimental evidence on the role of Trp
129 and Leu
324 in
governing the oxidation capacity and/or regio-selectivity of
CYP5136A3 for oxidation of PAHs and APs.
Materials and Methods
Strains, media, chemicals, and growth conditions
The microbial strains, plasmids and primers used in this study
are listed in Table 1. Media and growth conditions used for
culturing E. coli TOP10 and Pichia pastoris KM71H (henceforth
abbreviated as PP) were as described in the Pichia expression
manual (Invitrogen, USA). PAH compounds (phenanthrene and
pyrene), technical grade nonylphenol (tNP), 4-n-nonylphenol (4-n-
NP) and 4-n-octylphenol (4-n-OP), 9-phenanthrol, and 1-hydro-
xypyrene were obtained from Sigma-Aldrich (St. Louis, MO). 4-n-
Heptylphenol (4-n-HTP), 4-n-pentylphenol (4-n-PTP), 4-n-butyl-
phenol (4-n-BP), and 4-n-propylphenol (4-n-PP) were purchased
from Fisher Scientific (Pittsburg, PA). 3-Phenanthrol was pur-
chased from Toronto Research Chemicals, Canada and 4-
phenanthrol from Chiron AS, Norway.
Heterologous co-expression of CYP5136A3 and Pc-CPR in
Pichia pastoris
A binary vector containing CYP5136A3 and homologous
reductase partner (Pc-CPR) cDNAs, generated in our recent
study [15] was used for heterologous expression of this P450 in P.
pastoris.
Site-directed mutagenesis
The binary vector containing the original coding sequence was
used as a template for creating the W129A, W129L, W129F, and
L324G mutants of CYP5136A3. The corresponding primers
shown in Table 1 were used to create the four mutations in
CYP5136A3 by using Strategene’s QuikChange Lightning Multi
Site-directed Mutagenesis Kit (Cat. No. 210515) following the
manufacturer’s instructions. Recombinant constructs (Table 1)
were sequenced to select a construct showing the desired mutation
for further studies.
Transformation and selection of recombinant P. pastoris
CYP5136A3 mutant clones
PmeI-linearized binary vector constructs (Table 1) containing the
desired mutation in CYP5136A3 (W129A, W129L, W129F, or
L324G) were transformed into PP using the Pichia Transformation
Kit (Invitrogen). Co-presence of CYP5136A3 (mutated) and Pc-
CPR in zeocin-resistant colonies resulting from the integrative
transformation was confirmed by genomic DNA PCR. Site-
specific genomic integration of the mutated CYP5136A3 and Pc-
CPR was analyzed using three sets of primers (Table 1). The
binding sites of the primers on respective DNA sequences are
shown in Figure S1. Primers specific for 59AOX region (P1FP) and
for Pc-CPR (P1RP) were used to confirm the exact location of
integration and the presence of Pc-CPR. Presence of CYP5136A3
was confirmed using gene-specific primers (P2FP & P2RP).
Primers specific for Pc-CPR (P3FP) and CYP5136A3 (P3RP) also
enabled confirmation of the intended tandem arrangement of
these genes. The clones containing the mutated CYP5136A3
forms W129A, W129L, W129F, and L324G were named as PP
W129A, PP W129L, PP W129F, and PP L325G, respectively. For
each mutant, two positive colonies were compared for use in
expression analysis; as both the colonies showed the same level of
expression, data are presented for only one colony. A PP clone
expressing the wild type (WT) form of CYP5136A3 protein along
with the homologous reductase Pc-CPR (named as PP WT) and a
PP clone containing the empty vector (named as PP C), both
generated in our recent study [15], were used as positive and
negative controls, respectively.
Co-expression of CYP5136A3 enzyme and its mutant
forms with the homologous cytochrome P450 reductase
(Pc-CPR) in P. pastoris
Recombinant protein expression in the PP clones generated
above was carried out per manufacturer’s instructions (Pichia
expression manual, Invitrogen) using slight modifications [15].
Briefly, a single colony from each PP clone was inoculated into
buffered minimal glycerol (BMG) medium (100 ml) and the
cultures incubated at 30uC using 250 rpm speed until the optical
density (OD) at 600 nm reached 2.0. Cells were pelleted by
centrifugation (5000 g for 5 min), washed once with buffered
minimal solution and resuspended in buffered minimal methanol
(BMY) medium (21 ml) containing 0.5% methanol and aminole-
vulenic acid (2 mM) followed by incubation at 30uC and 250 rpm
for 48 h. The cells were again pelleted and resuspended in 5 ml of
lysis buffer (50 mM potassium phosphate buffer pH 7.4, 20%
glycerol, 1 mM PMSF, and protease inhibitor cocktail). The cells
were disrupted by vortexing (15 cycles of alternate pulsing and
cooling for 30 s each on ice) using an equal volume of acid-washed
glass beads. The total volume was made up to 30 ml with lysis
buffer and centrifuged at 5,000 g for 10 min at 4uC to remove cell
debris. Supernatant was collected and centrifuged at 20,000 g for
30 min at 4uC to remove mitochondria. The resulting supernatant
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resuspended in 4 ml of lysis buffer and the resulting microsomal
preparation was used for confirming the expression of CPR and
CYP5136A3 (mutant and wild type) proteins. P450 and CPR
expression analysis in microsomes was done based on reduced
CO-difference spectrum and NADPH-dependent cytochrome c
reducing activity, respectively, as described elsewhere [28].
Homologous CPR (Pc-CPR) expression in the microsomes was
confirmed by SDS-PAGE.
Whole cell assays for P450 catalytic activity analysis
To assess the capability of wild type and mutant forms of the
CYP5136A3 enzyme, we performed whole cell-based P450
oxidation activity towards phenanthrene, pyrene and APs. The
method employed for analysis of the oxidation activity was the
same as described previously for PAHs [15]. Briefly, a single
colony from each recombinant clone (PP C, PP WT, PP W129A,
PP W129L, PP W129F, and PP L324G) was cultured as described
above until the optical density (OD) at 600 nm reached 2.0. Cells
were pelleted and resuspended in buffered minimal (BM) medium
(21 ml) containing aminolevulenic acid (2 mM). The cell suspen-
sion was subdivided equally (7 ml each) into three conical flasks.
Each flask was spiked with the test xenobiotic compound dissolved
in methanol. All compounds were tested at 20 ppm final
concentration and the concentration of the vehicle (methanol),
which was also the carbon source in the medium, did not exceed
0.5% (v/v). An uninoculated control for estimation of the initial
level of the compound and for assessing the degree of any abiotic
degradation was prepared using the same medium and run along
side the test flasks. All treatments were performed in triplicate. The
cultures were incubated (30uC, 250 rpm) for 48 h. At 24 h time-
point, the cultures were spiked with methanol at 0.5% final
concentration. At 48 h, 5 ml culture aliquots were removed
aseptically and extracted (36) with an equal volume of methylene
chloride. The solvent extracts were dried on anhydrous sodium
sulfate and resuspended in acetonitrile. Simultaneously, 1 ml of
the final culture was centrifuged and the cell pellet dried to
estimate the dry biomass weight, as described elsewhere [29].
Chemical analysis and metabolite identification
Organic extracts, prepared for individual PP clones incubated
with different xenobiotic substrate compounds as described above,
were filtered through 0.45-mm glass fiber filters and analyzed using
Prostar 210/215 HPLC system (Varian, Inc.) equipped with a C18
reverse-phase column (4.6 mm6250 mm) and a UV detector.
Separation was achieved using a 20-min linear gradient of
acetonitrile (ACN) in water (60% to 100% for phenanthrene;
70% to 100% for pyrene; 50% to 100% for tNP, 4-n-NP and 4-n-
OP) or 25-min linear gradient of ACN in water (50% to 90% for
4-n-HTP; 50% to 80% for 4-n-PTP; 50% to 60% for 4-n-BP and
4-n-PP) at a flow rate of 2 ml/min. HPLC gradient for
phenanthrene and pyrene metabolites was as follows: 50%
Table 1. Strains, plasmids and primers used in this study.
Strain name Genotype/Phenotype Reference or source
E. coli TOP 10 F– mcrA D(mrr-hsdRMS-mcrBC) W80lacZDM15 DlacX74 recA1 araD139 D(ara leu) 7697
galU galK rpsL (StrR) endA1 nupG
Invitrogen
Pichia pastoris KM71H (PP) Mut
s,A r g + Invitrogen
PP C Pichia pastoris KM71H containing empty vector pPICZB 15
PP WT Pichia pastoris KM71H expresses Pc-CPR and Pc-CYP5136A3 15
PP W129A Pichia pastoris KM71H expresses Pc-CPR and mutated Pc-CYP5136A3 (W129A) This work
PP W129L Pichia pastoris KM71H expresses Pc-CPR and mutated Pc-CYP5136A3 (W129L) This work
PP W129F Pichia pastoris KM71H expresses Pc-CPR and mutated Pc-CYP5136A3 (W129F) This work
PP L324H Pichia pastoris KM71H expresses Pc-CPR and mutated Pc-CYP5136A3 (L324G) This work
Plasmids
Pc-CPR-CYP5136A3 Binary vector construct that contains homologous reductase (Pc-CPR) and CYP5136A3
in pPICZB vector background
15
Pc-CPR-CYP5136A3 (W129A) Binary construct that contains mutated CYP5136A3 (W129A) This work
Pc-CPR-CYP5136A3 (W129L) Binary vector construct that contains mutated CYP5136A3 (W129L) This work
Pc- CPR-CYP5136A3 (W129F) Binary vector construct that contains mutated CYP5136A3 (W129F) This work
Pc-CPR-CYP5136A3 (L324G) Binary vector construct that contains mutated CYP5136A3 (L324G) This work
Primers Sequence (59 to 39)
W129A CACCGGCAAGAGTATTCTGGCGGCACCTGATGGCAACACG This work
W129L CACCGGCAAGAGTATTCTGGTGGCACCTGATGGCAACACGC This work
W129F CACCGGCAAGAGTATTCTGTTCGCACCTGATGGCAACACGC This work
L324G GTCTGCGCTCACCGGTGCCGGCCACGAGACGACC This work
P1 FP GGCCCAAAACTGACACTTTAAACGCTGTCTTGG This work
P1 RP GGTCTAGACTACGACCAGACATCCAACAATAGGCG This work
P2 FP GGTACCTTCGAAACGATGGCTGTGATCGACTATACGCTCCACGCG This work
P2 RP & P3RP GCGGCCGCGTAGACGGTGACGTGAAG This work
P3 FP GAATTCGAAACGATGGCCGTCTCTTCGTCTTCGGACG This work
doi:10.1371/journal.pone.0028286.t001
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hold at 100% methanol for 2 min and 50% methanol for 3 min.
PAHs and their metabolites were detected at 254 nm whereas APs
and their metabolites were detected at 277 nm, and both groups of
compounds were quantified based on standard curves generated
using their known concentrations of parent compounds.
APs and their P450-hydroxylated metabolites were analyzed by
liquid chromatography-electrospray mass spectrometry (LC-ESI/
MS) using the LTQ-Orbitrap coupled with a surveyor MS Pump
Plus (Thermo Finnigan) as described previously [15]. The solvent
system was comprised of water and methanol, each supplemented
with ammonium acetate at 10 mM final concentration. The LC
gradient was as follows: 50% methanol for 5 min, a 45 min linear
gradient of increasing methanol in water (50% to 90% for 4-n-NP
and 4-n-OP; 50% to 90% for 4-n-HTP; 50% to 80% for 4-n-PTP;
50% to 60% for 4-n-BP and 4-n-PP), followed by a hold at 100%
methanol for 6 min and 50% methanol for 4 min. A survey MS
scan from m/z (100–500) at 30,000 resolution in the Orbitrap was
paralleled by data dependent MS2, MS3, and MS4 scans at
normalized collision energies of 25, 35 and 45, respectively. The
results were analyzed using XCalibur (Thermo) and the
experimental masses of metabolites were calculated by averaging
25 scans. The fragmentation patterns obtained from the MS
n
scans were compared with those reported in the literature [30,31].
P450 homology modeling and ligand docking
simulations
Two 3D homology-based models of CYP5136A3 were
generated using the Phyre server [32] based on human
microsomal P450 templates, CYP3A4 (PDB ID 1tqn) and
CYP1A2 (PDB ID 2hi4). Docking simulations of the substrates
were conducted with AutoDock 4 [33]. Analysis of ligand docking
results was performed using POLYVIEW-MM [34]. Identification
of critical amino acid residues involved in substrate recognition
was done using multiple sequence alignment by ClustalW2 [35]
and structure alignment by Dali [36]. Volumes of the active site
cavities were calculated with CASTp [37] using a 1.4 A ˚ probe.
Statistical analysis
The substrate oxidation activities and the ratios of metabolites
for different clones were analyzed for means and standard
deviations and compared for statistical differences by Student t
test using GraphPad QuickCalcs software package (GraphPad
software, Inc. CA, USA).
Results
Oxidation of alkylphenols by CYP5136A3
HPLC analysis of the reaction extracts from the whole cell-
based P450 assays on tNP showed almost complete (98%)
reduction of the parent compound (tNP) peak and appearance of
a metabolite peak in PP WT (P. pastoris clone expressing native
form of CYP5136A3 along with homologous reductase partner Pc-
CPR) compared to PP C( P. pastoris clone containing empty
PPICZB vector) (Figure 1a). There was no change in the tNP levels
in the PP C and the un-inoculated control cultures, suggesting that
the native PP P450s were not involved in tNP oxidation and that
the observed oxidation activity in PP WT was due to the
heterologously expressed CYP5136A3.
Analysis of the catalytic specificity of CYP5136A3 towards tNP
was difficult as it contains a mixture of over 100 p-isomers [27] that
generate an array of oxidized metabolites showing the overlapping
separation peaks and variable hydroxylation patterns. Hence,
individual linear APs (analytical grade) were employed to
determine the CYP5136A3 substrate specificity and catalytic
selectivity. As shown in Figure 1b, PP WT cells oxidized a number
of APs with linear alkyl side-chain length ranging from C3 to C9,
albeit to a variable extent. The C3-C5 chain-length APs including
4-n-propylphenol (PP), 4-n-butylphenol (BP), and 4-n-pentylphenol
(PTP) were oxidized to a greater extent (93–95%) as compared to
the C9 congener 4-n-nonylphenol (NP, 61%). APs with C8 (4-n-
octylphenol, OP) and C7 (4-n-heptylphenol, HTP) alkyl-chain
lengths showed 78% and 89% oxidation, respectively. The PP C
and PP WT cultures grown in the presence of different APs yielded
the same biomass, indicating that there is no stimulatory or
inhibitory effect of heterologous P450 expression on growth rate,
and that the observed oxidation activity differences are due to the
expressed CYP5136A3.
Figure 1. Oxidation of endocrine-disrupting alkylphenols by
CYP5136A3 in whole cell catalysis using P. pastoris recombi-
nant clones. a. HPLC analysis of the reaction extracts prepared form
the cultures of PP C (vector only) and PP WT (CYP5136A3-expressing)
clones incubated with technical grade nonylphenol (tNP). The values
represent means 6 standard deviations for three biological replicates.
b. Oxidation of linear side-chain alkylphenols individually (C3-C9 chain
length) and in mixture (tNP) by PP WT. Abbreviations: M, metabolite,
NP, 4-n-nonylphenol; OP, 4-n-octylphenol; HTP, 4-n-heptylphenol; PTP,
4-n-pentylphenol; BP, 4-n-butylphenol; PP, 4-n-propylphenol. There
were statistically significant (P#0.05) differences between the NP
oxidation rate and the oxidation rates of rest of the APs, and between
the OP oxidation rate and the PTP, BP and PP oxidation rates.
Differences among the oxidation rates for HTP, PTP, BP, and PP were
not statistically significant.
doi:10.1371/journal.pone.0028286.g001
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As observed in the HPLC chromatograms for tNP (Figure 1a),
the LC step of the LC-ESI/MS analysis on the PP WT reaction
extracts for the individual APs showed a single metabolite peak
when compared to the control PP C reaction extracts (Figure S2).
The identification of the metabolites was assisted by carrying out
accurate mass measurement with the Oribtrap on the whole
reaction extracts (Table 2). The experimentally determined m/z
values for the precursor ion of each AP metabolite [M-H]
2
suggested that they are aldehydes or epoxides or other structures
with the same elemental composition, rather than alcohol
metabolites (loss of two hydrogen atoms and gain of one oxygen
atom as compared to the parent compounds) (Table 2). In order to
further confirm the identity of the AP oxidation products as AP-
aldehydes, MS
n was employed to locate the position of the
functional group in the metabolites. As demonstrated by the
fragment ions of different AP metabolites under collision-induced
dissociation, fragmentation happened between the aromatic
moiety and the alkyl side-chain between the carbon atoms at
C1-C2 (105/106), C2-C3 (120), C3-C4 (134/135), C4-C5 (147/
148), C5-C6 (161), C6-C7 (173/175), C7-C8 (189/190) and C8-
C9 (203) (Figure 2). In addition, the presence of fragment ions with
an m/z value corresponding to the loss of CHO (29 amu) from the
parent ion of all the AP metabolites suggested that hydroxylation
occurred at the terminal carbon atom of the alkyl-chain in
different AP metabolites (Figure 2). The formation of aldehyde
rather than epoxide metabolites is further supported by the facts
that the substrate is a saturated alkane chain with no double bond
[38] and that similar terminal (v-) hydroxylations in yeasts yield
aldehyde metabolites due to the activity of the resident alcohol
dehydrogenases on the P450-hydroxylated intermediate [39].
Altogether, the molecular mass determined by mass measurements
(Table 2) and the metabolite fragmentation patterns (Figure 2)
confirmed that the aldehyde group is present at the terminal
carbon of the alkyl-chain in the metabolites of different APs
(Figure 2 and Table 2).
Structural analysis of CYP5136A3 protein
Three-dimensional homology-based models of CYP5136A3
were built using the Phyre web-server [32] based on appropriate
P450 templates. Among the 10 top-scoring templates selected by
Phyre, 2 templates corresponded to the mammalian P450s known
to oxidize PAHs [40] and other aromatic xenobiotics. These were
human microsomal P450s, CYP3A4 (PDB ID 1tqn) and CYP1A2
(PDB ID 2hi4), which showed 22% and 17% overall amino acid
sequence identity to CYP5136A3, respectively. Of these two
human P450s, 3A4 has a significantly larger active site cavity [21]
compared to 1A2 [22]. Structural alignment of the CYP5136A3
models showed 3.2 A ˚ RMSD (Figure S3). The model based on the
3A4 template was estimated to have the cavity with a volume of
5720.8 A ˚ 3. This volume includes the putative substrate access
channel. The volume of the cavity in the second model (based on
1A2) was estimated to be 2428.2 A ˚ 3, as this model did not indicate
presence of a substrate access channel. In this study, we have
chosen the 3A4-based model, as this template had a relatively
higher overall sequence identity with CYP5136A3 as compared to
other templates. In addition, sequence homology within the SRS
regions between CYP5136A3 and the mammalian CYP3A4
template constitutes 34% sequence identity (‘‘identity’’) and 58%
conservative identity (‘‘similarity’’). Major elements of the
CYP5136A3 topology are indicated in Figure S4, enabling the
approximate localization of the six substrate recognition sites
(SRS), SRS1-SRS6, typically present in a P450 protein [41,42].
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replaced by the unstructured loops.
The CYP5136A3 3D model was subsequently used for ligand
docking simulations by AutoDock 4 [33]. Structures of representa-
tive substrates, specifically phenanthrene, pyrene, and 4-n-nonyl-
phenol, were docked into the putative active site cavity. Contacting
residues were identified from the top-scoring poses of the substrates
(Figure 3a–c) using the POLYVIEW-MM server [34]. To pinpoint
the residues critical for substrate recognition, multiple sequence
alignment (MSA) was performed between the mammalian PAH
oxidases (CYPs 1A2 and 3A4) and the novel PAH-oxidizing fungal
P450s recently identified in our laboratory [15] (Figure 3d). Out of 7
residues found to contact all three docked substrates (W129, A321,
L324,A325,E328,T329,A395;Figure3d,residuesshadedinred),3
residues show significant variation across the aligned orthologs
(W129/SRS-1, A321/SRS-4, L324/SRS-4), 3 residues are highly
conserved (A325, E328, T329, all located in helix I/SRS-4), and 1
residue (A395, located in close proximity to SRS-5; not shown) has
no counterpart in other enzymes according to MSA. A395 is located
in the flexible loop region of the model, beyond the substrate
recognition site. Based on our analysis of the resolved crystal
structures of 3A4 [21] and 1A2 [22], we reasoned that the three
highly conserved residues, being also involved in heme binding, may
play a dual role (as per the crystal structure analysis; Figure 3d,
residues shaded in green); hence the mutation of these residues may
abolish heme binding, an undesirable effect for this study. The same
consideration related to A321. Therefore, we selected the remaining
two residues (W129 and L324) for site-directed mutagenesis (SDM)
from the list of residues that showed significant variation.
Comparison of P450 and CPR expression levels for WT
versus mutant clones of CYP5136A3
The effects of the mutations in terms of the expression levels of
the P450 (CYP5136A3) and its oxidation capacity towards
Figure 2. LC-ESI/MS/MS analysis of the oxidation products generated from different alkylphenols (APs). Collision-induced dissociation
fragmentation pattern is shown for the metabolite formed from each of the tested APs. a. 4-n-propylphenol. b. 4-n-butylphenol. c. 4-n-pentylphenol.
d. 4-n-heptylphenol. e. 4-n-octylphenol. f. 4-n-nonylphenol. Arrows in the structures of the individual AP oxidation products illustrate the observed
fragmentation pattern (based on reference 31).
doi:10.1371/journal.pone.0028286.g002
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PP clones with the control-positive (PP WT) and control-negative
(PP C) clones.
Microsomes from the PP clones expressing WT, W129A,
W129L, W129F, and L324G forms of CYP5136A3 showed
characteristic reduced CO-difference P450 spectrum as opposed
to no such spectrum observed in the microsomes prepared from
PP C (Figure 4a). CYP5136A3 WT and mutated forms showed the
maximum absorption peak at 448 nm (Figure 4a). Comparable
levels of expression of the P450 protein (in the range of 49–
53 pmol of P450/mg of microsomal protein) were observed in
microsomes prepared from both PP WT and PP clones containing
the mutated CYP5136A3 (Figure 4b).
Microsomes from all five PP clones (PP WT, PP W129A, PP
W129L, PP W129F, and PP L324G) showed high CPR activity at
comparable levels (Figure 4c), in the range of 1095–1151 nmol/
min/mg protein. In comparison, the PP C microsomes showed
negligible native yeast CPR activity (50 nmol/min/mg protein). In
order to further verify that the higher levels of CPR activity in the
recombinant clones are due to the expression of cloned Pc-CPR,
SDS-PAGE profiles of the microsomal proteins were compared.
An intense band corresponding to Pc-CPR (Figure 4d) in the
microsomal preparations from the PP clones WT, W129A,
W129L, W129F, and L324G as opposed to no such band in the
PP C microsomes confirmed that the high CPR activity in the
recombinant PP clones (WT, W129A, W129L, W129F, and
L324G) is due to actual expression of the cloned Pc-CPR.
Comparison of the xenobiotic-oxidizing activity of WT
versus mutant forms of CYP5136A3
Whole cell catalysis assays using the PP WT and mutant PP
clones allowed assessment of the catalytic role of Trp
129 and
Figure 3. Putative binding modes of the xenobiotic substrates obtained from ligand docking simulation in the CYP5136A3
homology-based model. a. Phenanthrene. b. Pyrene. c. 4-n-Nonylphenol. Residues colored cyan are in contact with the substrate. d. Two
fragments of the same multiple sequence alignment of P450s that are known to be PAH oxidases. Color highlighting: green– residues contacting
heme, magenta– residues in contact with co-crystallized ligand, red– a union of residues in contact with the three test substrates.
doi:10.1371/journal.pone.0028286.g003
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324 residues of CYP5136A3 in the oxidation of different APs
and PAHs (phenanthrene and pyrene).
HPLC profiles of the reaction extracts showed no considerable
effect (p.0.05) of the W129A mutation on the extent of oxidation
of either PAHs or APs (Figure S5). However, unlike W129A,
W129L and W129F mutations caused significant decrease
(p,0.05) in the oxidation of both PAHs and APs (Figure 5). PP
W129L showed higher reduction (81%) in phenanthrene oxidation
activity as compared to PP W129F (56%), and both clones showed
a significant decrease (76% by PP W129L and 88% by PP W129F)
in pyrene oxidation (p,0.05). For APs, PP W129F showed a
substantial loss in APs oxidation (60% for C9 AP and 28–41% for
Figure 4. Recombinant co-expression and activity analysis of CYP5136A3 or its mutant forms (W129A, W129L, W129F, and L324G)
and the homologous P450 reductase (Pc-CPR) partner in P. pastoris. Expression characteristics of the recombinant enzymes were assessed in
the yeast microsomes. a. characteristic reduced CO-difference spectra (the presented spectrum was chosen from a set of eight runs for each P450;
the maximum absorbance value varied from 446 nm to 451 nm with 448 nm being the most frequently recorded i.e. the mode value). b. P450
content. c. CPR activity (NADPH-dependent cytochrome c reducing activity). d. SDS-PAGE analysis of the microsomal protein preparations from
recombinant P. pastoris clones. Lanes labeled 1 through 6 represent microsomal fractions prepared form PP C, PP WT, PP W129A, PP W129L, PP
W129F, and PP L324G recombinant clones, respectively. CPR activity analysis was performed in triplicate; the means and standard deviations were
calculated. M indicates protein molecular weight marker. Expression of Pc-CPR is shown with an arrow. The differences in P450 quantities and CPR
activities in microsomes across the recombinant clones were not statistically significant (P$0.05).
doi:10.1371/journal.pone.0028286.g004
Figure 5. Relative PAH- and AP-oxidizing activities of the mutant forms of CYP5136A3. Percent loss of oxidation activity in the mutant
clones (PP W129L, PP W129F and PP L324G) relative to the PP WT clone (which expresses wild type CYP5136A3), was calculated by considering the PP
WT oxidation of PAHs and APs as 100%. The values represent means 6 standard deviations for three biological replicates. Asterisks indicate values
that are statistical significant (P#0.05) for a given compound between recombinant clones. Abbreviations: Phe, phenanthrene; Pyr, pyrene; NP, 4-n-
nonylphenol; OP, 4-n-Octylphenol; HTP, 4-n-heptylphenol; PTP, 4-n-pentylphenol; BP, 4-n-butylphenol; PP, 4-n-propylphenol.
doi:10.1371/journal.pone.0028286.g005
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of oxidation activity for C3-C8 APs (83–90%) and a comparable
loss in oxidation activity for C9 AP.
The L324G mutant caused a nearly complete impairment of
NP oxidation (95%) when compared to the WT form. Further-
more, it showed almost 50% lower level of oxidation activity in
case of OP, HTP and PP as compared to WT (Figure 5).
Oxidation levels for medium-chain APs, such as PTP and BP,
were decreased to 21% and 36% (compared to WT form),
respectively. The mutant clones (PP W129A, PP W129F, PP
W129L, and PP L324G) yielded the same biomass as the wild type
(PP WT) and the control (PP C) yeast clones, indicating (i) no
adverse effect of the P450 mutations on the rates of growth, and (ii)
that the oxidation activity differences among the clones are due to
the P450 mutations.
Regio-selectivity of WT versus mutant forms of
CYP5136A3
The metabolite profiles for PAHs (phenanthrene and pyrene)
and APs (varying in alkyl-chain lengths) were compared between
WT and the mutants. The HPLC and LC-ESI/MS analysis of the
xenobiotic reaction extracts prepared using PP W129A, PP
W129L, PP W129F, and PP L324G showed differences in
metabolite profiles for phenanthrene and pyrene as compared to
PP WT (Table 3).
WT enzyme oxidized phenanthrene into three metabolites viz.
3-phenanthrol, 4-phenanthrol and 9-phenanthrol in a ratio of
5.8:40.7:53.5. A different ratio (4.4:32.0:63.6) was observed in case
of W129A mutant indicating that this mutation caused a decrease
in the formation of 3-phenanthrol (21.4%) and 4-phenanthrol
(28.7%), and an increase in the formation of 9-phenanthrol
(+10.1%). Interestingly, in contrast with W129A, the W129F
mutation (which showed a 3-, 4-, 9-phenanthrols ratio of
6.6:45.4:48.0) caused a decrease in 9-phenanthrol (25.5%) level,
and an increase in 3-phenanthrol (+0.8%) and 4-phenanthrol
(+5.5%) levels compared to the WT form. W129L also followed
the same trends as W129F and caused a higher level of 4-
phenanthrol formation (+6.3%) and a lower level of 9-phenathrol
(+4.1%) formation as compared to WT. On the other hand, the
L324G mutant showed a large difference in the ratio of
phenanthrene metabolites as compared to W129A and WT; the
observed 0.1:0.9:99.0 ratio indicated an increased formation of 9-
phenanthrol (+45.5%) and a decreased formation of 3- and 4-
phenanthrols (25.7% and 239.8%, respectively) when compared
to WT. Interestingly, when calculated separately, just for the 3-
phenanthrol:4-phenanthrol ratio, it was comparable among the
WT, W129A, and W129F, but appeared shifted for L324G
towards a higher proportion of 4-phenanthrol (Table 3).
Analysis of the pyrene reaction extracts further suggested
differences in the metabolites ratio between PP WT and the
mutants (Table 3). WT oxidized pyrene into two metabolites, 1-
hydroxypyrene and 2-hydroxypyrene in a ratio of 36:64 suggesting
that the formation of 2-hydroxypyrene was favored over 1-
hydroxypyrene formation. Notably, mutations at both positions
(W129A, W129L, and L324G) led to a further increase in the
levels of 2-hydroxypyrene formation (Table 3), resulting in the
following ratios between the two metabolites: 24.7:75.3 (W129A),
26.5:73.5 (W129L), and 17.5:82.5 (L324G). PP W129F showed no
detectable metabolites in the HPLC profiles due to low levels of
pyrene oxidation by this mutant.
Discussion
CYP5136A3 as an AP alkyl side-chain v-hydroxylase
Alkylphenols have endocrine-disrupting activity, in that they are
known to mimic mammalian estrogenic hormones [43]. This
activity is attributed to both alkyl side chains and phenolic
moieties, which highlights the importance of biodegradation of the
side-chains of these estrogenic compounds. Previous metabolite
identification-based studies on certain species of yeast and fungi
have shown their ability to metabolize the model AP congener 4-n-
NP via terminal oxidation of the alkyl side-chain followed by a b-
oxidation pathway [4,5,9]. The remaining aromatic ring is then
cleaved and used as a carbon source [9]. However, specific
Table 3. Comparison of the metabolite profiles in P. pastoris clones expressing the wild type form (PP WT) and the mutant forms
(PP W129A, PP W129L, PP W129F, and PP L324G) of CYP5136A3.
Clone Phenanthrene metabolites
a 3:4 ratio
b Pyrene metabolites
a
3-OH phe 4-OH Phe 9-OH Phe 3-OH Phe 4-OH Phe 1-OH Pyr 2-OH Pyr
c
PP WT 5.8(60.1) 40.7(62.4) 53.5(62.5) 12.5 87.5 36(62.7) 64.0(63.4)
PP W129A 4.4(60.3) 32.0
*(61.9) 63.6
*(62.3) 12.1 87.9 24.7
*(62.5) 75.3
*(63.1)
PP W129F 6.6(60.5) 45.4
*(61.1) 48.0
*(60.6) 12.8 87.2 - -
PP W129L 3.6(60.5) 47.0
*(61.9) 49.4
*(61.2) 6.8 93.2 26.5
*(61.3) 73.5
*(62.1)
PP L324G 0.1
*(60.02) 0.9
*(60.5) 99.0
*(60.6) 7.2 92.8 17.5
*(62.7) 82.5
*(62.3)
aFor each metabolite, the observed HPLC count value was converted into metabolite concentration using the standard curve generated with the known quantity of the
metabolite (X-axis) and its HPLC count value (Y-axis). The proportion of each metabolite (%) was calculated from the total amount of metabolites (observed for each
oxidation reaction) which was considered as 100%. Values represent means 6 standard deviations (in parenthesis) based on three biological replicates. Asterisks
indicate values that are statistical significant (P#0.05) compared to PP WT. Formation of 3-OH Phe is a random event [50,52] and hence it is not an indication of regio-
selectivity by the mutants. All clones (PP WT, PP W129A, PP W129F and PP L324G) showed comparable product recovery (89–92% product recovery) for phenanthrene.
For pyrene, HPLC absorbance values were used to quantify the amounts of the oxidation products in PP W129A, PP W129L, and PP W324G compared to the PP WT
sample and the product recoveries are shown in the table. Due to low levels of pyrene oxidation by PP W129F, the metabolite level was below detection limit.
Abbreviations: 3-OH Phe, 3-phenanthrol; 4-OH Phe, 4-phenanthrol; 9-OH Phe, 9-phenanthrol; 2-OH Pyr, 2-hydroxypyrene; 1-OH Pyr, 1-hydroxypyrene.
bThe ratio between 3-phenanthrol and 4-phenanthrol was calculated on a scale of 100. Due to low levels of pyrene oxidation by PP W129F, the metabolite level was
below detection limit. The mechanism of oxidation of phenanthrene followed the NIH shift mechanism as all the mutants showed higher levels of 4-phenanthrol
compared to 3-phenanthrol. See text for details.
cIn light of the commercial non-availability of an authentic standard for 2-pyreneol, we used the molecular mass and the HPLC elution profile criteria to tentatively
identify the second peak as 2-pyrenol [15]; both profiles matched with the CYP101 mutants’ pyrene oxidation profile [72], where 1-pyrenol had longer retention time as
compared to 2-pyrenol.
doi:10.1371/journal.pone.0028286.t003
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have not been identified in these lower eukaryotes.
Our recent report on inducibility of CYP5136A3 by tNP in P.
chrysosporium [12] and the data in this study on complete oxidation
of tNP by recombinant CYP5136A3 collectively suggest that this
compound is both an inducer and a substrate for this enzyme. The
extent and rate of the oxidation (almost 100% oxidation of
20 ppm tNP in 48 h) pointed to the promising potential of the
CYP5136A3 enzyme as a catalyst for use in bioremediation of
tNP. Our results showed that CYP5136A3 possesses a broad
substrate-specificity towards linear APs with alkyl-chain length
ranging form C3 to C9. Based on the results of this work,
CYP5136A3 appears to preferentially target primarily short alkyl-
chain APs, such as PTP, BP, and PP, over the longer alkyl-chain
APs, such as NP and OP. Activity towards HTP was moderate
(intermediate between the short and the long alkyl-chain
containing APs).
In the whole cell P450 biocatalysis assays for APs, an aldehyde
metabolite accumulated, rather than the expected hydroxylated
AP, suggesting that the resident host yeast (P. pastoris) dehydroge-
nase activity is involved in further oxidation of the hydroxylated
AP metabolite generated by the recombinant fungal P450
(Figure 6). This is analogous with the n-alkane v-oxidation
pathway in alkane-utilizing yeasts [39] that proceeds via removal of
terminal carbon from the n-alkane chain by successive hydroxyl-
ation and oxidation reactions mediated by P450 monooxygenase,
alcohol dehydrogenase, and aldehyde dehydrogenase, respectively.
In order to confirm the CYP5136A3 catalytic specificity towards
APs, identifying the location of the functional group (aldehyde) in
AP-metabolite is critical. Mass fragmentation of the metabolite
showed that the aldehyde group is located at the terminal carbon
of the alkyl-chain of each tested AP metabolite, confirming that
CYP5136A3 is an alkyl side-chain v-hydroxylase (Figure 6). The
observed v-hydroxylation of varying chain-length (C3-C9) APs
implied that this P450 plays a role in fungal biodegradation of APs
via sequential shortening of the side-chain. This is consistent with
our whole fungus-based studies on another structurally-related
compound, the linear alkylbenzene sulfonate by P. chrysosporium,
wherein sequential shortening of the 12-carbon linear alkyl chain
was demonstrated [44].
Catalytic role of Trp
129 and Leu
324 residues of CYP5136A3
in oxidation of APs and PAHs
A homology-based 3D model of CYP5136A3, combined with
ligand docking simulations, suggested that Trp
129 and Leu
324
residues play a key role in the catalytic activity of this enzyme.
ClustalW2 alignment of the amino acid sequence of CYP5136A3
with those of the mammalian orthologs showed limited variability
in mammals at the positions corresponding to CYP5136A3 W129
and L324 (Figure 7). Specifically, at position 129, the majority of
mammalian enzymes harbor Phe, whereas fungal P450s display a
broad variability. Notably, human CYP3A4 (with very broad
substrate specificity), used as a template for CYP5136A3 model,
also differs at 129 from the other aligned human P450s, supporting
our hypothesis that this is one of the critical positions responsible
for versatile substrate recognition. At position 324, mammalian
enzymes have either a hydrophobic and aromatic amino acid
(Phe), or a polar amino acid (Gly), whereas fungal P450s have
hydrophobic aliphatic amino acid residues only (Ala, Val, and
Leu). In this context, homology-based modeling and site-directed
mutagenesis reports on mammalian P450s have shown that these
residues are critical in substrate binding and oxidation for various
substrates [45–49], although no studies are available on alkylphe-
nols as well as on the tested PAH compounds (phenanthrene,
pyrene).
In order to assess the role of Trp
129 and Leu
324 in the oxidation
of PAHs and APs, we replaced Trp
129 with amino acids of
increasing hydrophobic gradient (Ala, Phe, and Leu with the Kyte-
Doolittle hydropathy indices 1.8, 2.8, and 3.8, respectively, as
opposed to 20.9 for Trp) and hydrophobic Leu
324 with polar Gly
(a conserved residue within the selected mammalian PAH-
oxidizing P450s). Collectively, these mutations were intended to
confirm our homology model-based predictions on the catalytic
role of these amino acids. This also allowed us to understand the
catalytic relevance (specificity and/or regio-selectivity) of these
residues in the fungus compared to their mammalian counterparts
in this catalytic group of P450s (Figure 7).
Mutation of Trp
129 (W129A, W129L, and W129F) and Leu
324
(L324G) residues in CYP5136A3 caused no adverse effect on the
active expression of the mutant forms of CYP5136A3 as revealed
by the unaltered typical CO-difference spectrum (Figure 4).
Comparable levels of redox partner (Pc-CPR) expression in the
mutant clones (PP W129A, PP W129L, PP W129F, and PP
L324G) versus the control clone (PP WT) enabled uniform supply of
electrons for the wild type and mutant forms (W129A, W129L,
W129F, and L324G) of CYP5136A3. This directly supported the
interpretation that the observed differences in the oxidation profile
of PAHs and APs are due to the effect of mutations and not
because of the differences in supply of electrons for the oxidation
reaction, nor of the unfolding of the enzyme.
Oxidation of Alkylphenols
Although information on P450 oxidation of alkylphenols is
available for certain mammalian P450s, studies on the P450
structure-activity relationship with respect to this group of
compounds have not been reported. Here we identified two
amino acid residues that play a key role in the oxidation of
alkylphenols by the P450 enzyme CYP5136A3 from the model
white-rot basidiomycetous fungus P. chrysosporium. Substitution of
Trp
129 with Leu (W129L) or Phe (W129F) caused loss of oxidation
of APs. W129L was deleterious, as it resulted in complete loss of
AP oxidation. This suggested that W129 of CYP5136A3 plays a
key role in the oxidation of APs. Like W129L and W129F, the
Leu
324 mutation (L324G) was also found to be critical for the AP
oxidation activity. Notably, L324G mutation caused a complete
loss of oxidation activity towards 4-n-nonylphenol, the most
Figure 6. Schematic representation of the pattern of oxidation of alkylphenols by P. pastoris cells expressing CYP5136A3.
Alkylphenols were oxidized at the terminal carbon atom (v-oxidation) of their alkyl side-chain by the CYP5136A3 activity and the resulting v-
hydroxylated AP metabolites were further oxidized to their respective v-aldehydes by the action of the known yeast host dehydrogenase activity.
doi:10.1371/journal.pone.0028286.g006
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a key role of L324 residue in alkylphenol oxidation activity. All
these mutations had no effect on regio-selectivity of hydroxylation
of APs as the metabolite profile was the same for the mutant forms
and the WT form. This is the first report across the phylogenetic
ranks on identification of critical residues in a P450 enzyme
involved in AP oxidation.
Oxidation of Phenanthrene
Phenanthrene, a three-ring PAH, has been used as a model
compound in various studies on the mammalian metabolism of
PAHs due to the presence of ‘‘K-region’’, a common structural
feature of carcinogenic PAHs [50,51]. Recombinant CYP5136A3
oxidized phenanthrene into three hydroxylated metabolites 3-, 4-,
and 9-phenanthrol, suggesting the formation of two trans-
dihydrodiols, (3,4 and 9,10). The three phenanthrols detected in
the study were likely formed either by dehydration of the trans-
dihydrodiols [52] or by rearrangement of the postulated arene
oxides [50]. Given that 1- and 2-phenanthrols, the products of
phenanthrene oxidation at 1,2-position, were not formed by
CYP5136A3, there is a major difference between this enzyme and
P450s from other eukaryotes. For instance, the zygomycete fungus
Cunninghamella elegans [53], marine animals, such as lobsters and
sharks [54], and mammals, have been reported to oxidize
phenanthrene at the three alternative (3,4-, 9,10-, and 1,2-)
positions [55–60]. Furthermore, unlike mammalian P450s (human
CYPs 1A1, 2A6, 2E1, 3A4, and 1B1; rat CYPs 1A1, 1A2, and
2B1; mouse CYPs 1A1, 1A2, and 2E1; guinea pig CYPs [55] and
P450s from marine animals [54]), where phenanthrene trans-9,10-
dihydrodiol is the predominant metabolite, CYP5136A3 showed
almost comparable proportions of trans-9,10-dihydrodiol and trans-
3,4-dihydrodiol (54:46), as indicated by the relative amounts of 9-
phenanthrol versus 3- and 4-phenanthrols (Table 3). Collectively,
this suggests that CYP5136A3 is unique among the phenanthrene-
oxidizing P450s as its forms only two trans-dihydrodiols, and that
these are in comparable proportions unlike in other eukaryotes.
Interestingly, the ratio between 3- and 4-phenanthrols followed the
NIH shift mechanism [50] as the amount of 4-phenanthrol was
relatively higher than that of 3-phenanthrol (Table 3).
While substitution of Trp
129 with Ala (W129A) had no effect on
the oxidation activity of CYP5136A3 towards phenanthrene,
substitution with Leu (W129L) and Phe (W129F) decreased the
oxidation of phenanthrene, with nearly a complete loss of
oxidation for W129L. Although W129A had no effect on the
overall oxidation level of phenanthrene, it altered the regio-
selectivity of CYP5136A3 towards 9-phenanthrol formation.
Interestingly, in contrast with the W129A mutation, W129F and
W129L mutations led to high levels of 4-phenanthrol and low
levels of 9-phenanthrol formation. This suggests that Trp
129 of
CYP5136A3 plays a key role in regio-selective oxidation of
phenanthrene at both K-region (9,10- C position) and non-K
region (3,4- C position).
L324G reduced the phenanthrene oxidation activity by half and
favored the formation of 9-phenanthrol compared to the WT
enzyme. While formation of 3- and 4-phenanthrols was slightly
lowered in W129A, L324G mutation led to negligible levels of
these phenanthrols. However, the ratio between 3- and 4-
phenanthrols in the W129A, W129F, and L324G mutants still
followed the NIH shift mechanism as in case of the WT form of
the enzyme (Table 3). This suggested Trp
129 and Leu
324 play a key
role in the positioning of the phenanthrene towards the
CYP5136A3 heme oxidation center. L324G converts the fungal
P450 regio-selectivity into the mammalian P450-like regio-
selectivity for phenanthrene (as indicated by altered dominance
of the 9,10- diol over the 3,4- diol form). Taken together, our
observations suggest that the two residues Trp
129 and Leu
324 are
critical in modulating the regio-selectivity of PAH oxidation.
Oxidation of Pyrene
CYP5136A3 oxidized pyrene into two monohydroxylated
metabolites, 1-pyrenol and 2-pyrenol in a ratio of 64:36 (Table 3)
suggesting this enzyme’s interaction with the non-K region of
pyrene. Interestingly, to our knowledge, no other P450 across the
prokaryotes and eukaryotes has been reported to yield any
additional pyrenol (other than 1-pyrenol) from pyrene [61–70].
Figure 7. Amino acid sequence alignment of the eukaryotic P450s capable of oxidizing polycyclic aromatic hydrocarbons (PAHs).
Context amino acid sequences corresponding to W129 (a) and L324 (b) of CYP5136A3 are shown (the specific amino acid position in each P450
corresponding to these residues is included in the parenthesis). Mammalian P450 sequences for human (H), rat (R), and mouse (M) were retrieved
from the Nelson P450 website (http://drnelson.uthsc.edu/CytochromeP450.html). Model white-rot fungus P. chrysosporium P450s capable of
oxidizing PAH compounds per our recent report [15] were used for comparison with the mammalian P450s. Amino acid residues corresponding to
W129 and L324 of CYP5136A3 are highlighted in bold and are shaded.
doi:10.1371/journal.pone.0028286.g007
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from Pseudomonas putida [71] was shown to enable generation of
both pyrenols; the CYP101 mutants also formed pyrene quinones
in addition to pyrenols [71]. However, CYP5136A3 and CYP101
mutants differ in the ratio for the two pyrenols. Various CYP101
mutants formed 1- and 2- pyrenols and the pyrene quinones in a
ratio of 84:10:6 (Y96A), 75:1:24 (Y96F), 35:0.5:64.5 (F87A-Y96F)
and 37:1:62 (F87L-Y96F), suggesting the predominance of 1-
pyrenol in the oxidation product mixtures [71]. In contrast,
CYP5136A3 showed lower levels of 1-pyrenol as compared to 2-
pyrenol. This suggested that CYP5136A3 is unique among the
pyrene-oxidizing P450s because it forms two monohydroxylated
products (pyrenols) and relatively low amount of 1-pyrenol. As
observed for phenanthrene, W129A mutation had a negligible
effect on the levels of pyrene oxidation, unlike the other
hydrophobic amino acid substitutions at this position which
caused 75% (W129L) and 88% (W129F) loss of pyrene oxidation.
L324G mutation caused decrease in the pyrene oxidation levels by
half. These observations collectively suggest that both W129 and
L324 residues are critical in the oxidation of PAHs. Although
mutations at Trp
129 (W129A and W129L) and Leu
324 (L324G)
favored the formation of 2-pyrenol, its amount was predominant
in L324G as compared to W129A and W129L, suggesting the role
of these amino acid residues in the regio-selectively of pyrene (1- C
position) oxidation. Because of the low level of pyrene oxidation by
W129F mutation and difficulty in quantification of its pyrene
metabolites, the role of this substitution in regio-selective oxidation
of pyrene is not clear.
In conclusion, this study led to functional characterization of the
first fungal P450 (CYP5136A3) with a broad catalytic ability to
oxidize both alkylphenols (with varying length alkyl side-chain)
and PAHs, the two highly toxic environmental contaminants. The
information generated is significant considering that the identified
P450 is part of the overall enzymatic apparatus in this versatile
fungal organism, and thus could be targeted for improved
bioremediation applications including those involving mixture of
these chemicals. Structure-activity analysis led to the identification
of two key catalytic amino acid residues (Trp
129 and Leu
324)
involved in substrate specificity and/or regio-selectivity for the
oxidation activity. This marks the beginning of our understanding
of the catalytically significant amino acid residues governing the
oxidation of alkylphenols and the tested fused-ring PAHs
phenanthrene and pyrene in this class of eukaryotic P450s [16–
20]. Outcome of the present study opens up avenues for further
structure-activity relationship analyses on similar P450s from other
fungi as well as higher eukaryotes.
Supporting Information
Figure S1 Schematic representation of the strategy employed
for screening of P. pastoris transformants for insertion of Pc-
POR and CYP5136A3 (mutated). The primer sequences used
are listed in Table 1. Binding site for each primer is shown
with an arrow.
(TIF)
Figure S2 LC-ESI/MS analysis profile of the alkylphenols (APs)
oxidation products from P. pastoris PP WT whole cell assays.
Extracted ion chromatograms for APs constructed with cut-off
molecular mass of 233.0–233.5 (NP metabolite), 219.0–219.2 (OP
metabolite), 205.00–205.13 (HTP metabolite), 177.05–177.10 (PTP
metabolite),163.05–163.10(BPmetabolite),and149.05–149.10(PP
metabolite). Inset: Extracted ion chromatograms-mass spectrum for
the respective AP metabolites. Abbreviations: NP, 4-n-nonylphenol;
OP, 4-n-octylphenol; HTP, 4-n-heptylphenol; PTP, 4-n-pentylphe-
nol; BP, 4-n-butylphenol; PP, 4-n-propylphenol.
(TIF)
Figure S3 Structure alignment (Dali server) of the two 3D
models of CYP5136A3 built based on human P450s CYP3A4
(PDB ID 1tqn) and CYP1A2 (PDB ID 2hi4) using the Phyre
server. Aligned tertiary structures of the models differ by 3.2 A ˚
root mean square deviation (RMSD). Rendered in blue is the
model based on the 3A4 template (t3A4); the yellow is based on
1A2 (t1A2).
(TIF)
Figure S4 Structure-based alignment of amino acid sequences
and corresponding secondary structure (SS) states of the
CYP5136A3 models. SS were computed by the DSSP program
and reduced to 3 states: H – a-helices, E – b-sheets, and L – loops.
Structurally non-equivalent residues are in lowercase. P450
topology (based on t3A4) is labeled alphabetically for helices and
numerically for sheets. Residues labeled with asterisk were
mutated in this study (W129A and L324G).
(TIF)
Figure S5 PAH- and APs-oxidizing activities of the wild-type
CYP5136A3 (PP WT) and mutant form of CYP5136A3 (PP
W129A). Oxidation of PAHs and APs by PP W129A clone was
comparable with PP WT. The values represent means 6 standard
deviations for three biological replicates. Abbreviations: Phe,
phenanthrene; Pyr, pyrene; NP, 4-n-nonylphenol; OP, 4-n-
Octylphenol; HTP, 4-n-heptylphenol; PTP, 4-n-pentylphenol;
BP, 4-n-butylphenol; PP, 4-n-propylphenol.
(TIF)
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